{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:42:51Z","timestamp":1769064171923,"version":"3.49.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2020.00125","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T09:59:59Z","timestamp":1583315999000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Association of a Variant of CNR1 Gene Encoding Cannabinoid Receptor 1 With Gilles de la Tourette Syndrome"],"prefix":"10.3389","volume":"11","author":[{"given":"Natalia","family":"Szejko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub Piotr","family":"Fichna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Safranow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Dziuba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cezary","family":"\u017bekanowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Janik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1176\/appi.neuropsych.16110310","article-title":"Preliminary evidence on cannabis effectiveness and tolerability for adults with tourette syndrome","volume":"29","author":"Abi-Jaoude","year":"2017","journal-title":"J. Neuropsychiatry Clin. Neurosci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1093\/hmg\/ddn089","article-title":"Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations","volume":"17","author":"Benzinou","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.biopsych.2004.01.005","article-title":"[123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1receptors before and after \u03949-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in Tourette patients","volume":"55","author":"Berding","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.psychres.2011.05.033","article-title":"Cannabinoids improve driving ability in a Tourette\u2019s patient","volume":"190","author":"Brunnauer","year":"2011","journal-title":"Psychiatry Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00702-014-1266-3","article-title":"Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents","volume":"122","author":"Buchmann","year":"2015","journal-title":"J. Neural Transm."},{"key":"B6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1001\/archpsyc.65.7.816","article-title":"Cannabinoid receptor 1 gene association with nicotine dependence","volume":"65","author":"Chen","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.euroneuro.2013.05.012","article-title":"Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder","volume":"23","author":"Denys","year":"2013","journal-title":"Eur. Neuropsychopharmacol. [Internet]"},{"key":"B8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.euroneuro.2008.05.003","article-title":"Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression","volume":"18","author":"Domschke","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1375\/twin.10.6.805","article-title":"Association between single nucleotide polymorphisms in the cannabinoid receptor gene (CNR1) and impulsivity in Southwest California Indians","volume":"10","author":"Ehlers","year":"2007","journal-title":"Twin Res. Hum. Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/gbb.12311","article-title":"Cannabinoid receptor 1 (CNR1) gene variant moderates neural index of cognitive disruption during nicotine withdrawal","volume":"15","author":"Evans","year":"2016","journal-title":"Genes Brain Behav."},{"key":"B11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neuropharm.2008.06.076","article-title":"Looking for the role of cannabinoid receptor heteromers in striatal function","volume":"56","author":"Ferr\u00e9","year":"2009","journal-title":"Neuropharmacology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1476-5381.2010.00723.x","article-title":"Adenosine-cannabinoid receptor interactions. implications for striatal function","volume":"160","author":"Ferr\u00e9","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/npp.2009.200","article-title":"Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues","volume":"35","author":"Filbey","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1006\/mcpr.1999.0249","article-title":"A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene","volume":"13","author":"Gadzicki","year":"1999","journal-title":"Mol. Cell Probes."},{"key":"B15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/ajmg.b.20159","article-title":"Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene","author":"Gadzicki","year":"2004","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet. [Internet]."},{"key":"B16","first-page":"145","article-title":"Basal ganglia peptidergic staining in Tourette syndrome. A follow-up study","volume":"58","author":"Haber","year":"1992","journal-title":"Adv. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/JCP.0b013e3181d236ec","article-title":"Oral\u202f??9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report","volume":"30","author":"Hasan","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1111\/j.1360-0443.2008.02292.x","article-title":"Marijuana withdrawal and craving: Influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes","volume":"103","author":"Haughey","year":"2008","journal-title":"Addiction"},{"key":"B19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/026988119300700411","article-title":"Effective treatment of Tourette\u2019s syndrome with marijuana","volume":"7","author":"Hemming","year":"1993","journal-title":"J. Psychopharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/adb.12762","article-title":"Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme","author":"Hindocha","year":"2019","journal-title":"Addict. Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/ajad.12273","article-title":"A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients","volume":"24","author":"Icick","year":"2015","journal-title":"Am. J. Addict."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18081739","article-title":"Speechlessness in Gilles de la Tourette syndrome: Cannabis-based medicines improve severe vocal blocking tics in two patients","volume":"18","author":"Jakubovski","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.55782\/ane-2014-1987","article-title":"The BTBD9 gene polymorphisms in Polish patients with Gilles de la Tourette syndrome","volume":"74","author":"Janik","year":"2014","journal-title":"Acta Neurobiol. Exp. (Wars)."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0136754","article-title":"Association of ADORA1 rs2228079 and ADORA2A rs5751876 polymorphisms with gilles de la tourette syndrome in the Polish population","volume":"10","author":"Janik","year":"2015","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neulet.2009.06.021","article-title":"Variations in the cannabinoid receptor 1 gene predispose to migraine","volume":"461","author":"Juhasz","year":"2009","journal-title":"Neurosci. Lett."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/brainsci7050047","article-title":"Significant tic reduction in an otherwise treatment-resistant patient with gilles de la tourette syndrome following treatment with nabiximols","volume":"7","author":"Kanaan","year":"2017","journal-title":"Brain Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/can.2017.0007","article-title":"Cannabinoid receptor 1 gene by cannabis use interaction on cb1 receptor density","volume":"2","author":"Ketcherside","year":"2017","journal-title":"Cannabis Cannabinoid Res. [Internet]."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/ajmg.b.31024","article-title":"Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with 5-HTTLPR affect the anxious phenotype","author":"Lazary","year":"2009","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/0024-3205(88)90575-9","article-title":"Elevated CSF dynorphin A [1-8] in Tourette\u2019s syndrome","volume":"43","author":"Leckman","year":"1988","journal-title":"Life Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/ajmg.b.32467","article-title":"Genetic variation in the endocannabinoid system and response to cognitive behavior therapy for child anxiety disorders","volume":"174","author":"Lester","year":"2017","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/sj.ijo.0803273","article-title":"Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength","author":"Mackie","year":"2006","journal-title":"Int. J. Obesity"},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780199796267.001.0001","volume-title":"Tourette syndrome. [Internet]. Tourette syndrome","author":"Martino","year":"2013"},{"key":"B33","first-page":"1","article-title":"Novel augmentation strategies in major depression","volume":"64","author":"Martiny","year":"2017","journal-title":"Danish Med. J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/00004583-199605000-00023","article-title":"Bilineal transmission and phenotypic variation of Tourette\u2019s disorder in a large pedigree","volume":"35","author":"Mcmahon","year":"1996","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu. Rev. Psychol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00213-013-2995-y","article-title":"Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment","volume":"227","author":"Mitjans","year":"2013","journal-title":"Psychopharmacol. (Berl)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ymgme.2007.01.002","article-title":"No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents","volume":"90","author":"M\u00fcller","year":"2007","journal-title":"Mol. Genet. Metab"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1753-2000-2-33","article-title":"Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa","volume":"2","author":"M\u00fcller","year":"2008","journal-title":"Child Adolesc. Psychiatry Ment. Health"},{"key":"B40","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1600-0447.1998.tb10127.x","article-title":"Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome","volume":"98","author":"Muller-Vahl","year":"1998","journal-title":"Acta Psychiatr. Scand."},{"key":"B41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1176\/ajp.156.3.495","article-title":"Treatment of Tourette\u2019s syndrome with delta-9-tetrahydrocannabinol [3]","volume":"156","author":"Muller-Vahl","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1300\/J175v02n03_10","article-title":"Combined treatment of Tourette syndrome with 9-THC and dopamine receptor antagonists","volume":"2","author":"Muller-Vahl","year":"2002","journal-title":"J. Cannabis Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1055\/s-2002-25028","article-title":"Treatment of Tourette\u2019s syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial","volume":"35","author":"M\u00fcller-Vahl","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4088\/JCP.v64n0417","article-title":"??9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial","volume":"64","author":"M\u00fcller-Vahl","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"B45","first-page":"713","article-title":"Genetics of Tourette Syndrome","volume-title":"Movement Disorders: Genetics and Models","author":"Paschou","year":"2014"},{"key":"B46","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1038\/sj.ijo.0803272","article-title":"The pharmacology of cannabinoid receptors and their ligands: an overview","volume":"30","author":"Pertwee","year":"2006","journal-title":"Int. J. Obesity"},{"key":"B47","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/09658211.2016.1172642","article-title":"Because difficulty is not the same for everyone: the impact of complexity in working memory is associated with cannabinoid 1 receptor genetic variation in young adults","volume":"25","author":"Ruiz-Contreras","year":"2017","journal-title":"Memory"},{"key":"B48","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3389\/fphar.2016.00309","article-title":"Cannabis and Cannabinoids: pharmacology, toxicology, and therapeutic potential (Google eBook) [Internet]","author":"Russo","year":"2013","journal-title":"Rev. Ther. Effects."},{"key":"B49","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000490668","article-title":"G1359A variant of the cannabinoid receptor gene (rs1049353) and obesity-related traits and related endophenotypes: a meta-analysis","volume":"73","author":"Sadeghian","year":"2018","journal-title":"Ann. Nutr. Metab"},{"key":"B50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0887-8994(87)90061-0","article-title":"Tourette syndrome","volume":"3","author":"Sandyk","year":"1987","journal-title":"Pediatr. Neurol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/088307388800300215","article-title":"Self-mutilation in Tourette\u2019s syndrome","volume":"3","author":"Sandyk","year":"1988","journal-title":"J. Child Neurol."},{"key":"B52","first-page":"177","article-title":"Clinical symptomatology, CSF neurotransmitter metabolites, and serum haloperidol levels in Tourette syndrome","volume":"35","author":"Singer","year":"1982","journal-title":"Adv. Neurol."},{"key":"B53","first-page":"60","article-title":"Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior","volume-title":"Experimental Brain Research","author":"Steiner","year":"1998"},{"key":"B54","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pscychresns.2015.05.005","article-title":"Brain structural and clinical changes after first episode psychosis: focus on cannabinoid receptor 1 polymorphisms","volume":"233","author":"Su\u00e1rez-Pinilla","year":"2015","journal-title":"Psychiatry Res. - Neuroimaging"},{"key":"B55","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/1039856216663737","article-title":"Severe motor and vocal tics controlled with Sativex\u00ae","volume":"24","author":"Trainor","year":"2016","journal-title":"Australas. Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1177\/1352458511432741","article-title":"Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CLBL genes","volume":"18","author":"Varad\u00e9","year":"2012","journal-title":"Mult. Scler. J"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1016\/j.celrep.2018.08.082","article-title":"De Novo sequence and copy number variants are strongly associated with tourette disorder and implicate cell polarity in pathogenesis","volume":"24","author":"Wang","year":"2018","journal-title":"Cell Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/ajg.2017.73","article-title":"Cannabinoid receptor type 1 and mu-Opioid receptor polymorphisms are associated with cyclic vomiting syndrome","volume":"12","author":"Wasilewski","year":"2017","journal-title":"Am. J. Gastroenterol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.neuron.2017.04.024","article-title":"De Novo coding variants are strongly associated with Tourette disorder","volume":"94","author":"Willsey","year":"2017","journal-title":"Neuron"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2012.00108","article-title":"On the role of cannabinoid CB1and\u202f??-opioid receptors in motor impulsivity","volume":"3","author":"Wiskerke","year":"2012","journal-title":"Front. Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2018.00199","article-title":"Detection of significant association between variants in cannabinoid receptor 1 gene (CNR1) and personality in African-American population","volume":"9","author":"Yao","year":"2018","journal-title":"Front. Genet."},{"key":"B62","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jns.2007.01.069","article-title":"Frontal dopaminergic abnormality in Tourette syndrome: a postmortem analysis","volume":"255","author":"Yoon","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/JCP.0b013e318283925e","article-title":"CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia","volume":"33","author":"Yu","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neulet.2017.12.034","article-title":"Association of the AADAC gene and Tourette syndrome in a Han Chinese cohort","volume":"666","author":"Yuan","year":"2018","journal-title":"Neurosci. Lett."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2020.00125\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T15:27:28Z","timestamp":1722526048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2020.00125\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":64,"alternative-id":["10.3389\/fgene.2020.00125"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2020.00125","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"article-number":"125"}}